JAMA Oncol.
2017 3 (1) 18-20. doi: 10.1001/jamaoncol.2016.3112.
Minimal Residual Disease as a Potential Surrogate End Point-Lingering Questions.
Gormley NJ, Farrell AT, Pazdur R
The information contained in this message and any attachments is intended for the addressee(s) only. If you are not the addressee, you may not disclose, reproduce or distribute this message. If you have received this message in error, please advise the sender and delete it from your system. Any personal data sent in reply to this message will be used in accordance with provisions of the Data Protection Act 1998 and only for the purposes of the Institute's work.
All messages sent by NICE are checked for viruses, but we recommend that you carry out your own checks on any attachment to this message. We cannot accept liability for any loss or damage caused by software viruses.
